Scientific programme

Scientific programme

This Congress will showcase a plethora of relevant topics in the exciting field of Transfusion Medicine, from recruitment of blood donors to the actual donation process, biology of blood cells, preparation of blood components, transfusion-transmitted infectious diseases, immunohaematology patient blood management, adverse transfusion events, cellular therapies, and much more. Follow the ISBT announcements for more information about Workshops and special sessions, such as the Young Investigator Breakfast Sessions.

The Local Day will be organised by the Canadian Society of Transfusion Medicine and will focus on 200 years of tranfusion medicine. More information about the programme of the Local Day, the ISBT Academy Day and the parallel sessions will be made available on this page. 

Young Investigators Breakfast

On Tuesday June 5, 2018 a breakfast is organized to informally bring Young Investigators (under 40 years old) together with Transfusion Medicine experts. The breakfast is held in room 401 in the Metro Convention Centre, Toronto. 

For more information click here

PROGRAMME PER DAY **

09.00 - 10.30Donors & Donation
09.00 - 09.30Donor eligibility and selection for apheresis
C. Poole (South Africa)
09.30 - 10.00Short and longer-term risk of donor apheresis
M. Neyrinck (Belgium)
10.00 - 10.30Establishing an apheresis service in a resource-limited setting
B. Pheng (Cambodia)
09.00 - 09.45Education and Training
09.00 - 09.45Using simulation for training in clinical transfusion medicine
A. Petrosoniak & K. Pavenski (Canada)
10.30 - 11.00Coffee break


11.00 - 12.30 Organisation and Quality
11.00 - 11.30What I know about quality now that I wish I'd known then
M. Smith (New Zealand)
11.30 - 12.00Training the quality team
L. Bust (South Africa)
12.00 - 12.30When things go badly: managing quality problems and complaints in transfusion medicine
T. Vuk (Croatia)
11.00 - 12.30 Transfusion-transmitted infectious diseases
11.00 - 11.30Introducing the I TRY IT program
B. Custer (USA)
11.30 - 11.45I TRY IT programme participants
I TRY IT Participants (Various)
11.45 - 12.30Discussion
12.30 - 13.30Lunch Break and Satellite Symposia

                

13.30 - 15.00Immunohaematology 
13.30 - 14.00What's new in the Kell and Gerbich blood group systems
P. Ligthart (Netherlands)
14.00 - 14.30And now there are 49: update on the MNS blood group system
C. Gassner (Switzerland)
14.30 - 15.00Kidd blood group system: only 3 antigens but what about the variants?
J. Hamilton (USA)
13.30 - 15.00Clinical transfusion practice
13.30 - 14.00What is ECMO, and why do we use it in critical illness?
To be confirmed
14.00 - 14.30Is it TACO, TRALI or something else?
M. Looney (USA)
14.30 - 15.00None too SMAll: the global challenge of severe malarial anaemia and its transfusion support
C. Cserti-Gazdewich (Canada) 
15.00 - 15.30Break

 

 

 

15.30 - 17.00Immunohaematology 
15.30 - 16.00After 70 years, serological RhD determination is still challenging: DNA to the rescue
M. Pisacka (Czech Republic)
16.00 - 16.30Getting comfortable with Rh blood group system terminologies and databases
F. Werner (Germany)
16.30 - 17.00Decision-making in complex obstetric cases: How to end up with a healthy baby in HDFN
M. Delaney (USA)
15.30 - 17.00Cellular therapies and haemovigilance
15.30 - 16.00Prevention and detection of bacterial contamination of cellular therapeutics
M. Stoermeer (Germany) 
16.00 - 16.30Adverse outcomes and substances of human origin: Cases from the NOTIFY Library
E. Petrisli (Italy)
16.30 - 17.00Safety and surveillance issues in stem cell marketing
D. Sipp (Japan)
17.45 - 21.00Opening Ceremony & Welcome Reception


08.30 - 10.00Donors and Donation
08.30 - 09.00Iron and brain development
To be announced
09.00 - 10.00SELECTED ABSTRACTS
08.30 - 10.00Immunobiology
08.30 - 09.00Drug induced haemolytic anaemia
To be announced
09.00 - 10.00 SELECTED ABSTRACTS
08.30 - 10.00Clinical 
08.30 - 09.00Challenges in PBM / Tools for PBM
P. Meybohm (Germany)
Questioning the benefit of restrictive transfusion practice in older adults
G. Simon (Australia)
09.00 - 10.00SELECTED ABSTRACTS
08.30 - 10.00Cellular Therapies
08.30 - 09.00Cord blood expansion with novel small molecule 
G. Sauvageau (Canada)
09.00 - 10.00SELECTED ABSTRACTS
08.30 - 10.00WP TTID
Overview of TTI WP mission, membership and activities
C. Seed (Australia)
Surveillance, risk assessment, and policy subgroup presentation
S. O'Brien (Canada)
Bacterial subgroup presentation
C. MacDonald (UK)
Parasite subgroup presentation
E. Bloch (USA)
08.30 - 10.00WP IT
Electronic identity control, replacement identification and multiple transfusions made easy in the OR/ER
J. Georgsen (Denmark) 
Visibility and access to blood products via technology
L. Bricks (USA)
Practical consideration in implementing RFID for the blood supply
S. Lam (Singapore)
10.00 - 10.30Coffee break
10.30 - 12.00Plenary Session: Arboviruses
10.30 - 12.00Insect disease vectors and their impact on human health
L. Harrington (USA)
10.30 - 12.00Malarial resistence
E. Leftler (UK)
10.30 - 12.00The immune role of platelets in malaria
B. McCorran (Australia)
12.00 - 14.00Lunch break
14.00 - 15.30Donors & donation
14.00 - 14.30Donor reactions
To be confirmed
14.30 - 15.30SELECTED ABSTRACTS
14.00 - 15.30Blood products
14.00 - 14.30Novel platelet products
R. Cardigan (UK)
14.30 - 15.30SELECTED ABSTRACTS
14.00 - 15.30Blood safety 
14.00 - 14.30Bacterial contamination - CBS experience
S. Ramirez Arcos (Canada)
14.30 - 15.30SELECTED ABSTRACTS
14.00 - 15.30Management & Organisation
14.00 - 14.30Emergency preparedness for mass casualty events
H. Doughty (UK)
14.30 - 15.30SELECTED ABSTRACTS
14.00 - 15.30Young investigators session
14.00 - 15.30SELECTED ABSTRACTS
15.30 - 16.00Coffee break
16.00 - 17.30Cellular therapies
16.00 - 17.30The use of cord blood in metabolic disorders and hypoxic brain injuries 
J. Kurtzberg (USA)
16.30 - 17.30SELECTED ABSTRACTS
16.00 - 17.30Blood products
16.00 - 17.30Pathogen inactivation technologies
D. Devine (Canada)
16.30 - 17.30SELECTED ABSTRACTS
16.00 - 17.30Safety 
16.00 - 16.30Donor history questionnaire – Pakistan
I. Shabber (Pakistan)
16.30 - 17.00Addressing Transfusion Transmitted malaria in Kenya
V. Magutu (Kenya)
17.00 - 17.30To be announced
16.00 - 17.30Immunobiology 
16.00 - 16.30Fc receptor polymorphisms
T. Kuijpers (Netherlands)
16.30 - 17.30SELECTED ABSTRACTS
16.00 - 17.30Clinical 
16.00 - 16.30Transfusion of neonates: evidence & complications
A. Keir (Australia)
16.30 - 17.30SELECTED ABSTRACTS
16.00 - 17.30WP Donors and donation
Complications of blood donation
C. Napoli (Italy)
Needle comlications
M. Townsend (USA)
Apheresis comlications
H. Vrielink (Netherlands)
08.30 - 09.30Jean Julliard Prize
08.30 - 09.30Introductory presentation
09.00 - 09.30Jean Julliard Prize Ceremony
09.30 - 10.00Coffee break
10.00 - 11.30Presidential Award Session
11.45 - 12.30ISBT General Assembly
Members of ISBT only
12.00 - 14.00Lunch break
14.00 - 15.30Donors & Donation
14.00 - 14.30MSM and blood donation 
S. Sauleda (Spain)
14.30 - 15.30SELECTED ABSTRACTS
14.00 - 15.30Blood Products
14.00 - 14.30To be announced
M. Reade (Australia)
14.30 - 15.30SELECTED ABSTRACTS
14.00 - 15.30Safety 
14.00 - 14.30Indian experience of introducing a haemovigilance scheme
A. Bist (India)
14.30 - 15.30SELECTED ABSTRACTS
14.00 - 15.30Immunobiology 
14.00 - 14.30To be announced
To be announced
14.30 - 15.30SELECTED ABSTRACTS
14.00 - 15.30Blood supply
14.00 - 14.30Towards a safe and sufficient blood supply in Africa
D. Kyeyune (Uganda)
14.30 - 15.30SELECTED ABSTRACTS
14.00 - 15.30WP Cellular Therapy
The current status of human platelet lysate production and manufacturing
T. Bernouf (Taiwan) 

Platelet based clinical therapies: where are we now?
C. Cohn (USA)
Novel new platelet derived products: science, regulation and the evolving role of blood banks
M. Koh (UK/Singapore)
15.30 - 16.00Coffee break
16.00 - 17.30Donors & Donation 
16.00 - 16.30Donor health
E. Di Angelantonio (UK)
16.30 - 17.30SELECTED ABSTRACTS
16.00 - 17.30Management & Organisation 
16.00 - 16.30The challenges of implementing the European good practice guidelines for blood components
J. Bikulciené (Lithuania)
16.30 - 17.00Development of standards and accreditation in Africa 
C. Tayou (Cameroon)
17.00 - 17.30SELECTED ABSTRACTS
16.00 - 17.30Immunobiology 
16.00 - 16.30ITP pathophysiology
M. Michelle (France) 
16.30 - 17.00TACO pathophysiology
R. Kapur (Sweden)
17.00 - 17.30To be announced
To be announced
16.00 - 17.30Clinical 
16.00 - 16.30Prevention & management of RBC Alloimmunisation in thalassemia
A.A. Pourfathollah (Iran)
16.30 - 17.30SELECTED ABSTRACTS
16.00 - 17.30WP Rare donors/terminology/immunohematology
Introduction
N. Thornton (UK)
Name that specificity: investigating and identifying complex and exotic Rh variants
T. Peyrard (France)
Making it all happen for patients with rare blood
V. Yahalom (Israel)
Cataloging blood group variation with the help of new tools
M.L. Olsson (Sweden)
16.00 - 17.30WP Blood supply management
Effective cold chain management
R. Tocchetti (Australia)
Outcome of survey on blood product wastage in developing countries
M. Yazer (USA) 
Challenges to emergency transfusion in developing/resource constrained countries
D. Kyeyune (Uganda)
17.45 - 18.45Poster session

                   

08.30 - 10.00Donors and Donation
08.30 - 09.00An overview of donor base models in Sub-Sahara Africa: challenges and successes
I. Bates (UK)
09.00 - 09.30Building a blood system: the view froum Saudi Arabia
M. Badawi (Saudi Arabia)
09.30 - 10.00SELECTED ABSTRACTS 

08.30 - 10.00Blood products
08.30 - 09.00Automated products
J. Cid (Spain)
09.00 - 10.00SELECTED ABSTRACTS
08.30 - 10.00Viruses
08.30 - 09.00To be announced
To be announced
09.00 - 10.00SELECTED ABSTRACTS
08.30 - 10.00Immunobiology
08.30 - 09.00Immunoglobulins in Transfusion medicine
G. Vidarsson (Netherlands)
09.00 - 10.00SELECTED ABSTRACTS
08.30 - 10.00Cellular therapy
08.30 - 09.00To be announced
To be announced
09.00 - 10.00SELECTED ABSTRACTS
08.30 - 10.00WP Clinical - paediatric subgroup
Comparison of UK and Australian PBM guidelines
G. Crighton (Australia)
Epidemiology: practice patterns and outcomes for children transfused for life threatening haemorrhage
P. Spinella (USA)
Neonatal and paediatric haemovigilance
H. New (UK)
10.00 - 10.30Coffee break
10.30 - 12.00Plenary Session: Platelets
10.30 - 11.00In vitro production of platelets
J. Thon (USA)
11.00 - 11.30Translational
A. Weyrich (USA)
11.30 - 12.00Clinical
To be announced
12.00 - 14.00Lunch break

        

14.00 - 15.30Donor Recruitment
14.00 - 14.30Recruitment and retention
To be announced
14.30 - 15.00To be announced
To be announced
15.00 - 15.30To be announced
To be announced
14.00 - 15.30Products 
14.00 - 14.30To be announced
To be announced
14.30 - 15.30SELECTED ABSTRACTS
14.00 - 15.30Clinical 
14.00 - 14.30Improving efficacy of audit and feedback to improve transfusion practice
S. Stanworth (UK)
14.30 - 15.30SELECTED ABSTRACTS
14.00 - 15.30Immunobiology 
14.00 - 15.30SELECTED ABSTRACTS
14.00 - 15.30Safety 
14.00 - 14.30Emerging infectious diseases
C. Erikstrup (Denmark)
14.30 - 15.30SELECTED ABSTRACTS
14.00 - 15.30WP Platelet
New discoveries in immune mediated thrombocytopenia: implications for diagnosis and therapy
H. Ni (Canada)
Platelet serology for allo and autoantibodies: pivotal or just nice to have?
U. Sachs (Germany)
Report on the 19th International Platelet Immunology workshop
L. Richard (Canada)
Generation of HPA-matched platelet precursors from humans iPS cells using CRISPR-mediated genome engineering
P. Newman (USA)
15.30 - 16.00Coffee Break
16.00 - 17.30Plenary session - Transfusion Medicine past, present and future
16.00 - 16.30Past
D. Starr (USA)
16.30 - 17.00Present
S. Dzik (USA)
17.00 - 17.30Future 
To be confirmed
17.30 Closing ceremony
20.00 - 23.00Congress Party / Banquet

          

Tuesday June 5, 2018 
7.00-8.15 hrs
Room 401, MTCC


The Young Investigators breakfast; an oppurtunity for Young Investigators (researchers under 40 years old) to meet a transfusion medicine expert, maybe one that you admire and look up to. Some of these experts will be at the breakfast and available to discuss your work and some of the challenges and joys of research and to give you tips for your ongoing work. 

The breakfast will take place in an informal setting in room 401, a room with a view in the Metro Convention Centre, Toronto.

Please fill in the application form and send it to science@remove-this.isbtweb.org by May 3, 2018.

Please note that to attend this session, you need to have a good understanding and be able to express yourself in English.

** Each parallel session will comprise (an) invited speaker(s) and selected abstracts for oral presentation.

JOIN ISBT TOGETHER WE INCREASE OUR IMPACT ON TRANSFUSION MEDICINE

Quote
Quote

“I think ISBT is the main forum for translating science and networking into best practices”

Morten Bagge Hansen, Denmark
Become a member from 55,- euro p/y Join us now